Anthony J. Polverino

CIK 1729957 · Chief Scientific Officer · last filed 2026-05-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$852.3K

Companies

2

Total Filings

20

Lifetime Open-Market Net

-$36.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BCLI Director 25,730 $0.75 $19.3K $0 8 2025-01-03
ZYME Chief Scientific Officer 36,407 $22.88 $833.0K -$36.6K 11 2022-01-07

Recent Filings · Page 2 of 2

20 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-07-06 ZYME Grant (A) +488 $15.0K EDGAR
2020-03-11 ZYME Grant (A) $0 EDGAR
2020-02-14 BCLI Grant (A) +5,071 $0 EDGAR
2020-01-09 ZYME Grant (A) +371 $7.2K EDGAR
2019-12-13 ZYME Exer (M) +27,500 $412.5K EDGAR
2019-07-10 ZYME Grant (A) +1,120 $14.0K EDGAR
2019-02-22 BCLI Grant (A) +3,501 $0 EDGAR
2019-01-10 ZYME Grant (A) $0 EDGAR
2018-11-30 BCLI Grant (A) +3,667 $0 EDGAR
2018-02-05 BCLI Grant (A) +3,623 $0 EDGAR
Showing 1120 of 20
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.